Vervet Research Colony as a Biomedical Resource

这个应用程序是一个竞争性的更新“作为生物医学资源的Vervet研究殖民地” (VRC，P40-OD 010965）。VRC是美国出生的唯一NIH资助的生物医学研究资源 非洲长尾猴/非洲绿色猴（AGM; Chlorocebus aethiops sabaeus），并一直得到资助 从2005年开始。VRC为广泛的地方，区域和国家调查人员提供服务， 动物、生物样本、数据、咨询和与使用长尾小蠹/AGM有关的培训 作为人类疾病的多类别转化模型。自上次更新以来，VRC 为100多名研究人员提供了资源，其中包括250多只动物和1500多只 生物样本以及数据和咨询。越南难民委员会还提供了必要的 基础设施和技术专业知识，使现场使用超过600动物在30 不同的研究。VRC促进了各种各样的关键翻译研究， 学科，包括：a）作为一种新兴的非人类灵长类动物模型的长尾猴的发展， 阿尔茨海默病的风险，重点是评估淀粉样蛋白负荷，神经退行性疾病 疾病生物标志物和突触变性; B）研究 新生儿流感、呼吸道合胞病毒等传染病疫苗， 登革热; c）研究重点是糖尿病的病因和健康后果，代谢 疾病和肥胖症; d）开发新的非侵入性生物医学成像方法; 和e）扩大可用于长尾猴的关键遗传资源，包括 对长尾雉基因组进行测序。VRC资源的目标是：1）提供科学的 社区能够获得动物、生物样本、数据和专门知识， 为广泛的生物医学研究提供研究机会; 2）提供特殊的培训机会 对于兽医和研究人员有兴趣使用长尾猴进行转化研究， 作为社区和科学推广的平台，以促进更好地了解使用 生物医学研究中的非人灵长类动物;和3）通过从事应用 研究的重点是继续在整个非洲大陆上对长尾猴的遗传和表型特征进行研究。 寿命和评价的vervet作为一个潜在的翻译模式，在新的研究领域。 VRC是维克森林临床和转化科学奖（CTSA）的重要组成部分， 它提供管理支持，并促进跨 更大的CTSA网络。VRC能够充分利用各种现有的 维克森林医学院的研究设施，包括多模态成像 能力、兽医和病理学专业知识以及遗传和分析资源。

This application is a competing renewal of the "Vervet Research Colony as a Biomedical Resource" (VRC, P40-OD010965). The VRC is the only NIH-funded biomedical research resource for US-born vervet/African green monkeys (AGM; Chlorocebus aethiops sabaeus) and has been continuously funded since 2005. The VRC serves a wide range of local, regional and national investigators by providing animals, biological samples, data, consultation and training pertaining to the use of vervets/AGMs as multi-categorical, translational models of human disease. Since the previous renewal, the VRC has provided resources to over 100 investigators, including over 250 animals and over 1,500 biological samples, as well as data and consultation. The VRC has also provided the necessary infrastructure and technical expertise enabling the on-site use of over 600 animals across 30 different studies. The VRC has facilitated critical translational research across a wide variety of disciplines, including: a) the development of the vervet as an emerging nonhuman primate model of Alzheimer's disease risk with a focus on the assessment of amyloid burden, neurodegenerative disease biomarkers, and synaptic degeneration; b) investigations into the efficacy and enhancement of vaccines for infectious diseases such as neonatal influenza, respiratory syncytial virus, and dengue fever; c) studies focused on the etiology and health consequences of diabetes, metabolic disease and obesity; d) the development of novel, non-invasive biomedical imaging methodologies; and e) the expansion of the critical genetic resources available for vervets, including the sequencing of the vervet genome. The aims of the VRC resource are to: 1) provide the scientific community with access to animals, biological samples, data and expertise to facilitate the use of vervets for a wide-range of biomedical research; 2) to provide exceptional training opportunities for veterinarians and researchers interested in using vervets for translational research, and to serve as a platform for community and scientific outreach to foster better understanding of the use of nonhuman primates in biomedical research; and 3) to enhance the resource by engaging in applied research focused on continuing genetic and phenotypic characterization of vervets across the lifespan and evaluation of the vervet as a potential translational model in novel research areas. The VRC is a critical component of the Wake Forest Clinical and Translational Science Award (CTSA), which provides administrative support and facilitates the utilization of the VRC resource across the larger CTSA network. The VRC is able to take full advantage of a wide-range of existing research facilities within the Wake Forest School of Medicine, including multi-modal imaging capabilities, veterinary and pathology expertise, and genetic and analytic resources.